Clinical trial
Effect of the Inhaled Triple Therapies Over the Small Airway in Patients With Chronic Obstructive Pulmonary Disease or Chronic Bronchitis Without Obstruction Secondary to Biomass Exposure: Randomized Controlled Clinical Trial Phase IV
NCT06571942 is registered in ClinicalTrials.gov with National Institute of Respiratory Diseases, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of the Inhaled Triple Therapies Over the Small Airway in Patients With Chronic Obstructive Pulmonary Disease or Chronic Bronchitis Without Obstruction Secondary to Biomass Exposure: Randomized Controlled Clinical Trial Phase IV
- Lead sponsor
- National Institute of Respiratory Diseases, Mexico
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 15, 2023
- Completion date
- January 15, 2025
- Enrollment
- 128 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd bronchitis, pollution related respiratory disorder